201 related articles for article (PubMed ID: 6979620)
41. [Immunodiagnosis of chronic lymphatic leukemia and leukemic non-Hodgkin's lymphoma with the monoclonal antibodies BL-Ig-L/1, BL-DR/1 and BL-T2].
Malberg K; Fischer H; Elendt D; Wutke K; Fiebig H
Arch Geschwulstforsch; 1984; 54(4):325-32. PubMed ID: 6437368
[TBL] [Abstract][Full Text] [Related]
42. Monoclonal antibody patterns in lymphomatoid papulosis.
Kaudewitz P; Burg G; Stein H; Klepzig K; Mason DY; Braun-Falco O
Dermatol Clin; 1985 Oct; 3(4):749-57. PubMed ID: 3842652
[TBL] [Abstract][Full Text] [Related]
43. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
[TBL] [Abstract][Full Text] [Related]
44. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
Negoro S; Seon BK
Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
[TBL] [Abstract][Full Text] [Related]
45. [Immunologic phenotype of blast cells in the diagnosis of myeloblastic leukemias].
Baryshnikov AIu; Volkova MA; Frenkel' MA; Tupitsyn NN; Morozova LF
Ter Arkh; 1985; 57(5):98-100. PubMed ID: 3895550
[TBL] [Abstract][Full Text] [Related]
46. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
47. Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.
Dorreen MS; Habeshaw JA; Stansfeld AG; Wrigley PF; Lister TA
Br J Cancer; 1984 Apr; 49(4):465-76. PubMed ID: 6370286
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of reactivity of HLA-Cw antisera by extending the incubation time.
Wong DM; Kumar R; Mittal KK
Acta Anthropogenet; 1983; 7(3):197-203. PubMed ID: 6335043
[TBL] [Abstract][Full Text] [Related]
49. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
50. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition.
Yamada K; Sachs DH; DerSimonian H
J Immunol; 1995 Dec; 155(11):5249-56. PubMed ID: 7594537
[TBL] [Abstract][Full Text] [Related]
51. Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells.
Vidal K; Samarut C; Magaud JP; Revillard JP; Kaiserlian D
J Immunol; 1993 Nov; 151(9):4642-50. PubMed ID: 8409425
[TBL] [Abstract][Full Text] [Related]
52. Immunopathology of Hodgkin's disease.
Strauchen JA
Pathol Immunopathol Res; 1986; 5(3-5):253-64. PubMed ID: 3110753
[TBL] [Abstract][Full Text] [Related]
53. An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel.
Abdulaziz Z; Mason DY; Stein H; Gatter KC; Nash JR
Histopathology; 1984 Jan; 8(1):1-25. PubMed ID: 6368356
[TBL] [Abstract][Full Text] [Related]
54. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
Nunez G; McPhaul J; Stastny P
Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
[TBL] [Abstract][Full Text] [Related]
55. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
56. [Immunological aspects of Hodgkin's disease].
Bianchini E
Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
[TBL] [Abstract][Full Text] [Related]
57. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
Nguyen DT; Diamond LW; Hansmann ML; Fischer R
Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732
[TBL] [Abstract][Full Text] [Related]
58. On the natural biology of the malignant cells in Hodgkin's disease.
Olsson L
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):37-48. PubMed ID: 3871433
[TBL] [Abstract][Full Text] [Related]
59. Detection of p53 in Hodgkin's disease using the monoclonal antibody PAb248.
Doussis-Anagnostopoulou I; Remadi S; Kaklamanis L; Pezzella F; Gatter KC
J Pathol; 1996 Feb; 178(2):170-2. PubMed ID: 8683384
[TBL] [Abstract][Full Text] [Related]
60. Immunophenotype of Reed-Sternberg cells.
Hugh J; Poppema S
Int Rev Exp Pathol; 1992; 33():81-114. PubMed ID: 1733873
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
